Fundraising Fox1859
San Diego, US · Founded 2019 · Delaware corporation · 2 known investors
Find your way into 1859
Sign up to see every warm intro you have to 1859
- Paths you didn't know you had: your email and LinkedIn already hold routes to the 1859 team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
JD
John DrewryNamed on SEC filing
AM
Andrew MacConnellNamed on SEC filing
PC
DC
Devon CayerNamed on SEC filing
Investors · 2
Northpond VenturesreportedBethesda · $100K – $5M
How we know: funding news · Not right? Tell us
OMX VenturesreportedLincolnshire
How we know: a partner's Signal profile · funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$52.2M disclosed across 4 rounds · 2019–2021
▶$40MraisedNov 2021 · 7 investors · BiotechnologyRule 506(b)
▶$40MraisedNov 2021 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Lily LiDirector
- John DrewryDirector
- Devon CayerExecutive Officer, Director
- Andrew MacConnellExecutive Officer, Director
- Dan FaroDirector
- Paul ConleyDirector
- Offering amount
- $40M
- Amount sold
- $40M
- First sale
- Nov 2021
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$2MraisedOct 2021 · 3 investors · BiotechnologyRule 506(b)
▶$2MraisedOct 2021 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- John DrewryDirector
- Andrew MacConnellExecutive Officer, Director
- Paul ConleyDirector
- Devon CayerExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $2M
- First sale
- Sep 2021
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$9.7MraisedSep 2021 · 8 investors · BiotechnologyRule 506(b)
▶$9.7MraisedSep 2021 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Devon CayerExecutive Officer, Director
- Paul ConleyDirector
- Andrew MacConnellExecutive Officer, Director
- John DrewryDirector
- Offering amount
- $9.7M
- Amount sold
- $9.7M
- First sale
- Aug 2020
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$500KraisedJul 2019 · 4 investors · BiotechnologyRule 506(b)
▶$500KraisedJul 2019 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Devon CayerExecutive Officer, Director
- John DrewryDirector
- Andrew MacConnellExecutive Officer, Director
- Offering amount
- $1.4M
- Amount sold
- $500K
- First sale
- Jun 2019
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are 1859's investors?
- 1859's investors include Northpond Ventures, OMX Ventures.
- How much funding has 1859 raised?
- 1859 has disclosed $52.2M raised across 4 rounds.
- Where is 1859 headquartered?
- 1859 is headquartered in San Diego, US.